Creatine Isn't Just for Lifters—Why Consistency Beats Dosing

Creatine and the Aging Brain: New Data on Maintenance, Not Miracles

A new randomized, placebo-controlled trial in older adults (average age 68) combined 3g daily creatine with resistance training over 16 weeks. The study tracked brain-derived neurotrophic factor (BDNF), oxidative stress, inflammation, strength, function, and cognition. While the protocol used resistance training alongside creatine—making isolated effects hard to parse—the dosing window is relevant: 3g sits closer to adequacy maintenance (our 525mg daily baseline) than performance intervention. The trial underscores that creatine's role in older populations isn't about unlocking superhuman capacity; it's about supporting baseline cellular energy in contexts where demand (training, aging) can otherwise outpace supply.

This study used 3g, roughly 6x our daily maintenance dose, paired with high-load training—a setup designed to stress-test capacity, not simulate everyday adequacy. We focus on a different question: can a lower, consistent dose prevent the slow cellular drain that comes from dietary gaps, especially in populations eating less meat or training moderately? The trial's design—older adults, structured exercise—fits the "don't let the tank run dry" model, even if the dose and context differ from ours. The takeaway: creatine matters across the lifespan, and meeting baseline needs is a hedge, not a hack.

The study's focus on BDNF and oxidative markers reflects creatine's role in cellular stress buffering, but these outcomes require context. We're not claiming cognitive enhancement or anti-aging breakthroughs from 525mg—those conversations live in clinical intervention territory. What this trial reinforces is that creatine stores aren't infinite, especially as we age or increase physical demand. Our ritual sits in the adequacy lane: meeting the newly published daily maintenance recommendation so you're not starting each day sub-optimally saturated. It's not dramatic. It's just not leaving free energy on the table.

Breaking Out of the Gym Aisle

We spent time this week talking to people who've never touched a tub of creatine powder — nutritionists, brain health advocates, people building in the longevity space. What stuck with us: they all had the same visceral reaction to creatine's current branding. They see the value, but the aesthetic and cultural baggage around muscle-building kept them from ever recommending it seriously.

The real unlock in these conversations wasn't validation that creatine matters for daily function — we already know that. It was watching the moment when someone realizes creatine only works with consistency over time, not acute loading. That's when Tortis clicks. If the entire point is long-term baseline maintenance, then the product that's easiest to take every single day wins. Not the one with the most servings per dollar or the loudest label. The one you don't have to think about.